NERVGEN PHARMA CORP. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-25. The offering totals $5.4M, of which $2.2M was reported sold. Industry: Other.
Showing 25 of 32 people.
| Name | Role | Location |
|---|---|---|
| Amy Franke | Executive Officer | Vancouver, A1 |
| Lloyd Mackenzie | Executive Officer | Vancouver, A1 |
| Krista McKerracher | Director | Boston, MA |
| Paul Brennan | Director | Oxford, X0 |
| Paul Brennan | Executive Officer | Oxford, X0 |
| Michael Abrams | Director | Wilmington, DE |
| William Adams | Executive Officer | PONTE VEDRA, FL |
| Ernest Wong | Director | Dallas, TX |
| Ernest Wong | Executive Officer | Dallas, TX |
| Harold Punnett | Director | Vancouver, A1 |
| Brian Bayley | Director | Vancouver, A1 |
| Bill Radvak | Director | Vancouver, A1 |
| Bill Radvak | Executive Officer | Vancouver, A1 |
| Randall Kaye | Director | Vancouver, A1 |
| Daniel Mikol | Executive Officer | Vancouver, A1 |
| Glenn Ives | Director | Vancouver, A1 |
| Brian Eric Bayley | Director | VANCOUVER, A1 |
| Robert Pilz | Executive Officer | VANCOUVER, A1 |
| Denis Bosc | Executive Officer | Vancouver, A1 |
| Harold Jeffrey Punnett | Director | Vancouver, A1 |
| William Joseph Radvak | Director | Vancouver, A1 |
| William Joseph Radvak | Executive Officer | Vancouver, A1 |
| William Joseph Radvak | Promoter | Vancouver, A1 |
| Brian Jeffrey Bayley | Director | Vancouver, A1 |
| Robert Joseph Pilz | Executive Officer | Vancouver, A1 |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2021-12-14 | D | $1.1M | $652K |
| 2021-08-25 | D/A | $5.4M | $2.2M |
| 2021-08-17 | D | $442K | $264K |
| 2021-06-02 | D/A | $650K | $285K |
| 2020-06-03 | D | $650K | $285K |
| 2019-11-22 | D | $1.5M | $1.5M |
| 2019-03-21 | D | $1.2M | $1.2M |
| 2018-09-20 | D | $111K | $111K |